January
Sunday 25 February 2018 photo 13/13
|
Palliative care syringe driver guidelines: >> http://uej.cloudz.pw/download?file=palliative+care+syringe+driver+guidelines << (Download)
Palliative care syringe driver guidelines: >> http://uej.cloudz.pw/read?file=palliative+care+syringe+driver+guidelines << (Read Online)
syringe driver compatibility uk
mckinley syringe driver guidelines
syringe driver prescription example
palliative care syringe driver medications
syringe driver drug calculations
how to set up a syringe driver
syringe driver medication chart
syringe driver medication doses
Literature Review & Development of Clinical Practice Guidelines. This revised edition of the 'The Guidelines for Subcutaneous Infusion. Device Management in Palliative Care' takes account of the October. 2007 withdrawal from sale in Australia of the Graseby syringe driver, a subcutaneous infusion device that was the
Clinical protocol for the use of syringe drivers in palliative care patients (adults). These guidelines are written for the use of health care professionals in the Oxford Radcliffe NHS Trust and were produced by Mandie Draper and Stuart Oliver CNS?s in the Trust?s Hospital Palliative Care Teams who will review the protocol
eg Zomorph 60 mg bd = 120 mg ? morphine 60 mg/24 hours via syringe driver. Ensure that adequate breakthrough doses are written up prn - they should be the equivalent of 1/6 of the 24 hour driver dose (ie 10 mg morphine prn in above example). To convert from other opioids, contact pharmacy or the Palliative Care Team.
attached charts or by consulting a pharmacist or palliative care specialist, or by contacting Medicines Information (contact numbers listed in Appendix 1). Information is also available from the following resources: • The Oxford Textbook of Palliative Medicine. • Palliative Care Formulary. • The Syringe Driver -continuous
3 Jun 2014 Use the current local protocols for setting up and monitoring the syringe pump you are using. The tables in this guideline contain information about preparations, dose ranges, diluents and indications for single drugs that can be given by subcutaneous infusion for symptom control in palliative and end of life
Continuous subcutaneous administration of medicines using a syringe driver often becomes necessary for the control of symptoms during palliative care. A syringe driver is useful when the oral Hospice New Zealand offers a training programme on managing syringe drivers in primary care. For further information see:
Before setting up or using a syringe driver, staff must familiarise themselves with the manufacturer's instruction booklet and locally developed clinical guidelines. Following are the operating management principles. The standard delivery period for a continuous subcutaneous infusion in palliative care is 24 hours.
Results 1 - 10 of 121 During the terminal phase of a person's illness, secretions may accumulate in the airway and result in gurgling and rattling noises during inspiration and expiration (sometimes described as a 'death More: Guidance · Palliative care - dyspnoea. Source: Clinical Knowledge Summaries - 24 January 2017.
The PRN dose is calculated as 1/6 of the 24 hour dose. e.g. oral MST 90mg BD = 180mg oral morphine/24 hours = 60mg subcutaneous diamorphine per 24 hour syringe; breakthrough pain dose = 1/6 of daily dose i.e.10mg diamorphine per 4 hours subcutaneously.
Guidelines for Syringe Driver Management in Palliative Care. Developed by: Victoria J. Kain. Project Officer, Centre for Palliative Care Research and Education. Professor Patsy Yates. Acting Director, Centre for Palliative Care Research and Education; and Queensland University of Technology. In consultation with:.
Annons
Visa toppen
Show footer